Global Tauopathies Treatment Market, by Disease (Frontoyemporal Degenration [Pick`s Disease, CBD, and PSP], Alzheimer`s Disease, and Other Neurodegenerative Diseases), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is expected to be valued at US$ 712.7 million in 2020 and is estimated to exhibit a CAGR of 10.07% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/3995...
|
